Edgar Filing: MAGELLAN HEALTH INC

Ownership Submission

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0104

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Â Kamal Mostafa

2. Date of Event Requiring Statement (Month/Day/Year)
07/01/2015

3. Issuer Name and Ticker or Trading Symbol
MAGELLAN HEALTH INC [MGLN]

(Last)

(First)

(Middle)

15950 NORTH 76TH STREET,Â SUITE 200

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
CEO, Magellan Rx Management

5. If Amendment, Date Original Filed(Month/Day/Year)

(Street)

SCOTTSDALE,Â AZÂ 85260

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security
(Instr. 4)

2. Amount of Securities Beneficially Owned
(Instr. 4)

3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)

4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (right to buy)	Â ⁽¹⁾	04/01/2025	Common Stock	5,000	$ 71	D	Â
Stock Option (right to buy)	Â ⁽¹⁾	03/04/2025	Common Stock	4,441	$ 63.95	D	Â
Stock Option (right to buy)	Â ⁽²⁾	03/05/2023	Common Stock	157	$ 53	D	Â
Restricted Stock Units	Â ⁽³⁾	Â ⁽⁴⁾	Common Stock	525	$ ⁽⁴⁾	D	Â
Performance Stock Units - 3/4/15	Â ⁽⁵⁾	Â ⁽⁴⁾	Common Stock	395	$ ⁽⁴⁾	D	Â
Performance Stock Units (EPS) 3/5/14	Â ⁽⁶⁾	Â ⁽⁴⁾	Common Stock	29	$ ⁽⁴⁾	D	Â
Performance Stock Units (ROE) 3/5/14	Â ⁽⁶⁾	Â ⁽⁴⁾	Common Stock	29	$ ⁽⁴⁾	D	Â
Performance Stock Units (EPS) 3/5/14	Â ⁽⁶⁾	Â ⁽⁴⁾	Common Stock	29	$ ⁽⁴⁾	D	Â
Performance Stock Units (ROE) 3/5/14	Â ⁽⁶⁾	Â ⁽⁴⁾	Common Stock	28	$ ⁽⁴⁾	D	Â
Performance Stock Units (C) 3/5/13	Â ⁽⁶⁾	Â ⁽⁴⁾	Common Stock	29	$ ⁽⁴⁾	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Kamal Mostafa 15950 NORTH 76TH STREET SUITE 200 SCOTTSDALE,Â AZÂ 85260	Â	Â	Â CEO, Magellan Rx Management	Â

Signatures

/s/ Mostafa Kamal		07/10/2015
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Options shall vest and become exercisable in one-third increments on March 4 of each of 2016, 2017 and 2018.
(2)	of the 472 options granted, 315 have previously vested and exercised. The remainder of 157 options shall vest on March 5, 2016.
(3)	Restricted Stock Units shall vest in one third increments on March 5 of each of 2016, 2017 and 2018.
(4)	Not applicable.
(5)	Performance Stock Units shall vest on March 4, 2018.
(6)	Performance Stock Units shall vest on March 5, 2016 subject to performance restrictions.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.